(3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone

C71H106ClIN12O12 — CID 156690859

IUPAC(3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone
SMILESCC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)C[C@@H](C(=O)N2CCCCC2)N(C)C(=O)[C@H](CC(C)C)NC(=O)C(C)(C)N(C)C(=O)[C@H](CC=C(C)C)NC(=O)[C@H](Cc2cccc(I)c2)NC(=O)CN(C)C(=O)[C@H](Cc2ccc(Cl)cc2)N(C)C(=O)[C@@H]2CCN2C(=O)[C@H](C)N(C)C1=O
InChIInChI=1S/C71H106ClIN12O12/c1-18-45(8)60-69(96)79(13)46(9)63(90)85-34-31-54(85)67(94)82(16)56(39-47-26-28-49(72)29-27-47)66(93)78(12)41-58(86)74-52(38-48-23-22-24-50(73)37-48)61(88)75-51(30-25-42(2)3)65(92)83(17)71(10,11)70(97)76-53(35-43(4)5)64(91)81(15)57(68(95)84-32-20-19-21-33-84)40-59(87)80(14)55(36-44(6)7)62(89)77-60/h22-29,37,43-46,51-57,60H,18-21,30-36,38-41H2,1-17H3,(H,74,86)(H,75,88)(H,76,97)(H,77,89)/t45-,46-,51-,52-,53-,54-,55-,56-,57-,60-/m0/s1
InChIKeyAKSLTAPAGNOHHH-MQMGOWAZSA-N
MW1482.06 g/mol
LogP5.20
Rot. Bonds13

About (3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone

(3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone (PubChem CID 156690859) has the molecular formula C71H106ClIN12O12 and a molecular weight of 1482.06 g/mol. Its IUPAC name is (3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone.

Molecular Properties

Compound Name(3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone
PubChem CID156690859
Molecular FormulaC71H106ClIN12O12
Molecular Weight1482.06 g/mol
Exact Mass1480.68
IUPAC Name(3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone
SMILESCC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)C[C@@H](C(=O)N2CCCCC2)N(C)C(=O)[C@H](CC(C)C)NC(=O)C(C)(C)N(C)C(=O)[C@H](CC=C(C)C)NC(=O)[C@H](Cc2cccc(I)c2)NC(=O)CN(C)C(=O)[C@H](Cc2ccc(Cl)cc2)N(C)C(=O)[C@@H]2CCN2C(=O)[C@H](C)N(C)C1=O
InChIInChI=1S/C71H106ClIN12O12/c1-18-45(8)60-69(96)79(13)46(9)63(90)85-34-31-54(85)67(94)82(16)56(39-47-26-28-49(72)29-27-47)66(93)78(12)41-58(86)74-52(38-48-23-22-24-50(73)37-48)61(88)75-51(30-25-42(2)3)65(92)83(17)71(10,11)70(97)76-53(35-43(4)5)64(91)81(15)57(68(95)84-32-20-19-21-33-84)40-59(87)80(14)55(36-44(6)7)62(89)77-60/h22-29,37,43-46,51-57,60H,18-21,30-36,38-41H2,1-17H3,(H,74,86)(H,75,88)(H,76,97)(H,77,89)/t45-,46-,51-,52-,53-,54-,55-,56-,57-,60-/m0/s1
InChIKeyAKSLTAPAGNOHHH-MQMGOWAZSA-N
XLogP5.20
TPSA278.88 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds13
Heavy Atoms97
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001482.06
LogP ≤ 55.20
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'iodine', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone?
The IUPAC name of (3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone (CID 156690859) is (3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone.
What is the SMILES notation for (3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone?
The canonical SMILES for (3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone is CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)C[C@@H](C(=O)N2CCCCC2)N(C)C(=O)[C@H](CC(C)C)NC(=O)C(C)(C)N(C)C(=O)[C@H](CC=C(C)C)NC(=O)[C@H](Cc2cccc(I)c2)NC(=O)CN(C)C(=O)[C@H](Cc2ccc(Cl)cc2)N(C)C(=O)[C@@H]2CCN2C(=O)[C@H](C)N(C)C1=O.
What is the InChIKey of (3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone?
The InChIKey is AKSLTAPAGNOHHH-MQMGOWAZSA-N. The full InChI is InChI=1S/C71H106ClIN12O12/c1-18-45(8)60-69(96)79(13)46(9)63(90)85-34-31-54(85)67(94)82(16)56(39-47-26-28-49(72)29-27-47)66(93)78(12)41-58(86)74-52(38-48-23-22-24-50(73)37-48)61(88)75-51(30-25-42(2)3)65(92)83(17)71(10,11)70(97)76-53(35-43(4)5)64(91)81(15)57(68(95)84-32-20-19-21-33-84)40-59(87)80(14)55(36-44(6)7)62(89)77-60/h22-29,37,43-46,51-57,60H,18-21,30-36,38-41H2,1-17H3,(H,74,86)(H,75,88)(H,76,97)(H,77,89)/t45-,46-,51-,52-,53-,54-,55-,56-,57-,60-/m0/s1.
What are the key properties of (3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone?
(3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone has a molecular weight of 1482.06 g/mol, XLogP of 5.20, 13 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,6S,9S,13S,16S,22S,25S,31S,34S)-6-[(2S)-butan-2-yl]-31-[(4-chlorophenyl)methyl]-25-[(3-iodophenyl)methyl]-3,4,10,14,19,19,20,29,32-nonamethyl-22-(3-methylbut-2-enyl)-9,16-bis(2-methylpropyl)-13-(piperidine-1-carbonyl)-1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-2,5,8,11,15,18,21,24,27,30,33-undecone is sourced from PubChem (CID 156690859), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).